Cost-effectiveness of plasmapheresis and hemoperfusion in COVID-19 survivors: A six-month follow-up analysis after hospital discharge
Abstract
A six-month follow-up analysis examining the clinical outcomes and costs of plasmapheresis and hemoperfusion in patients who survived critical COVID-19, assessed after hospital discharge. The analysis found limited long-term cost-effectiveness for these extracorporeal therapies.
Type
Publication
Therapeutic Apheresis and Dialysis
Authors
PhD Student, Biomedical Informatics & Data Science
Physician-scientist and PhD student, focused on the evaluation and real-world implementation of clinical AI systems. My research centers on trustworthy clinical LLMs, including hallucination detection, evidence grounding, contextual reliability, and AI safety in healthcare settings. I develop evaluation frameworks and computational methods to determine whether clinical AI systems are scientifically grounded, clinically reliable, and suitable for deployment in real-world practice.